Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma

NCT03015389 is registered in ClinicalTrials.gov with CDx Diagnostics as lead sponsor.

NCT NCT03015389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03015389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma
Lead sponsor
CDx Diagnostics
Phase
Observational
Overall status
Completed
Start date
September 27, 2017
Completion date
February 18, 2019
Enrollment
170 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, esophageal adenocarcinoma, esophageal dysplasia